Skip to main content
Premium Trial:

Request an Annual Quote

LeukoDx Closes $1.6M Financing Tranche, Inks Agreements for up to $8M

NEW YORK (GenomeWeb News) – Flow cytometry technology firm LeukoDx today announced it has secured commitments of up to $8 million in investments during the next three years.

The funding is expected to bring the company's development of its point-of-care platform to the point of registration, it said.

LeukoDx has closed the initial $1.6 million tranche of the funding. Investors included an unnamed US private equity group, a European life science investor, and historical investors. The remainder of the investment will depend on certain milestones being reached, which the company said it expects to happen within the next two years.

Based in Towson, Md., and Jerusalem, LeukoDx is developing a platform for delivering flow cytometry in vitro diagnostic results in 10 minutes from a drop a blood on an automated disposable cartridge, its President and CEO, Julien Meissonnier, said. The platform potentially could expand the use of cell-based IVD tests, Meissonnier added.

As part of a planned clinical menu for measuring white blood cell activity, the company is developing an assay for CD64 neutrophil activation under a licensing deal with Trillium Diagnostics, LeukoDx said. The assay would allow for rapid clinical diagnosis in numerous patient settings, including neonatal and intensive care units, emergency departments, and remote locations without access to diagnostic medical laboratories, it added.

LeukoDx also is seeking to partner with biotechnology and IVD companies to expand the menu for its platform.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.